Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
45 Years to 65 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Women 45-65 years
naturally or surgically postmenopausal
experiencing hot flushes
hypersensitivity to estrogen replacement therapy
pregnancy or lactating
abnormal PAP smear
history/suspected cervical, uterine, adrenal, pituitary, breast or ovarian malignancy